Literature DB >> 30552114

Cytochrome P450 1A1 opens up to new substrates.

Andrew W Munro1.   

Abstract

The cytochromes P450 (CYPs) oxidatively transform a huge number of substrates in both prokaryotic and eukaryotic organisms, but the mechanisms by which they accommodate these diverse molecules remain unclear. A new study by Bart and Scott reports two co-crystal structures of CYP1A1 that reveal structural rearrangements and flexible interaction networks that explain how the active site cavity shapes itself around new ligands. These data open the door to an increased understanding of fundamental enzyme behavior and improved searches for anti-cancer compounds.
© 2018 Munro.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30552114      PMCID: PMC6302179          DOI: 10.1074/jbc.H118.006715

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Cytochrome P450-mediated bioactivation of the epidermal growth factor receptor inhibitor erlotinib to a reactive electrophile.

Authors:  Xiaohai Li; Theodore M Kamenecka; Michael D Cameron
Journal:  Drug Metab Dispos       Date:  2010-04-09       Impact factor: 3.922

2.  Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1.

Authors:  T Shimada; C L Hayes; H Yamazaki; S Amin; S S Hecht; F P Guengerich; T R Sutter
Journal:  Cancer Res       Date:  1996-07-01       Impact factor: 12.701

3.  Structural characterization of the complex between alpha-naphthoflavone and human cytochrome P450 1B1.

Authors:  An Wang; Uzen Savas; C David Stout; Eric F Johnson
Journal:  J Biol Chem       Date:  2010-12-08       Impact factor: 5.157

4.  Metabolism and excretion of erlotinib, a small molecule inhibitor of epidermal growth factor receptor tyrosine kinase, in healthy male volunteers.

Authors:  Jie Ling; Kim A Johnson; Zhuang Miao; Ashok Rakhit; Michael P Pantze; Marta Hamilton; Bert L Lum; Chandra Prakash
Journal:  Drug Metab Dispos       Date:  2005-12-28       Impact factor: 3.922

Review 5.  Metabolic activation of polycyclic aromatic hydrocarbons to carcinogens by cytochromes P450 1A1 and 1B1.

Authors:  Tsutomu Shimada; Yoshiaki Fujii-Kuriyama
Journal:  Cancer Sci       Date:  2004-01       Impact factor: 6.716

Review 6.  What makes a P450 tick?

Authors:  Andrew W Munro; Hazel M Girvan; Amy E Mason; Adrian J Dunford; Kirsty J McLean
Journal:  Trends Biochem Sci       Date:  2013-01-26       Impact factor: 13.807

7.  Human cytochrome P450 1A1 structure and utility in understanding drug and xenobiotic metabolism.

Authors:  Agnes A Walsh; Grazyna D Szklarz; Emily E Scott
Journal:  J Biol Chem       Date:  2013-03-18       Impact factor: 5.157

8.  Structures of human cytochrome P450 1A1 with bergamottin and erlotinib reveal active-site modifications for binding of diverse ligands.

Authors:  Aaron G Bart; Emily E Scott
Journal:  J Biol Chem       Date:  2018-09-25       Impact factor: 5.157

Review 9.  Targeting cytochrome P450 enzymes: a new approach in anti-cancer drug development.

Authors:  Robert D Bruno; Vincent C O Njar
Journal:  Bioorg Med Chem       Date:  2007-05-23       Impact factor: 3.641

10.  Adaptations for the oxidation of polycyclic aromatic hydrocarbons exhibited by the structure of human P450 1A2.

Authors:  Stefaan Sansen; Jason K Yano; Rosamund L Reynald; Guillaume A Schoch; Keith J Griffin; C David Stout; Eric F Johnson
Journal:  J Biol Chem       Date:  2007-02-20       Impact factor: 5.157

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.